A combination of antiarrhythmic drugs and radiofrequency catheter ablation successfully managed ventricular arrhythmias in a pediatric patient with ARVD over a 4-year follow-up.
May support combined therapy in one pediatric ARVD case; leaves open generalizability and optimal strategy.
Arrhythmogenic right ventricular dysplasia (ARVD) is a complex arrhythmogenic cardiomyopathy, characterized by a partial or total replacement of the right ventricular myocytes by fatty and fibrous tissue. In this study, we present a case of ARVD in 17 year old girl, who was admitted to the hospital after syncope with ventricular arrhythmia. The echocardiography did not demonstrate structural cardiac abnormalities but the magnetic resonance recently showed thinning of the right ventricular wall. The girl was treated with the lidocaine, amiodarone and next, after radiofrequency catheter ablation she was receiving metoprolol. The girl has remained asymptomatic for four years of follow-up.
No takes yet. Share an insight, caveat, or question.
Markiewicz‐Łoskot et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: